Follow Us:
Opioid 101:
Contact us:
Thank you! We’ve sent you an email to confirm your address.
Q&A
How a Businessman, After Losing a Son, Is Battling to Fix Opioid Addiction Treatment
When Gary Mendell’s son Brian needed addiction treatment, money was never an object.
Stanford’s Lembke: Most high-dose opioid patients should be tapered down—even involuntarily.
When Anna Lembke first became a psychiatrist, addiction was an area she avoided.
Drug Policy Expert Robert DuPont: The Opioid Crisis is Now About Synthetics and Polydrug Use
Psychiatrist Robert L. DuPont, MD, has been campaigning against opioid addiction for half a century.
Adam Bisaga, MD, on Addiction, Chronic Pain, and Stigma
This is Part 2 of an interview with Adam Bisaga, MD, an addiction psychiatrist, clinician, researcher, and professor of psychiatry at Columbia University.
Adam Bisaga, MD: Referring Patients to Most Opioid Treatment Centers Is Now Unethical
Adam Bisaga, MD, is an addiction psychiatrist, clinician, researcher, professor of psychiatry at Columbia University, and author of Overcoming Opioid Addiction.
Prosecutor Dave Aronberg on the ‘Florida Shuffle’: Lethal Fraud in the Opioid Detox Industry
Florida is the nation's second most popular destination for for-profit drug detox, and Palm Beach County is the state's leader in that respect.
Q&A (Pt 2): Addiction Expert Discusses Hate Mail and Why Opioids are “Lousy” Drugs for Pain
Andrew Kolodny is co-director of the Opioid Policy Research Collaborative of the Heller School for Social Policy and Management at Brandeis University.
Q&A (Pt 1): Opioid Activist Andrew Kolodny Outlines the Origins of the Epidemic
About two years ago someone mailed a bag of nails to the home of Andrew Kolodny...
Q&A: Opioid Plaintiffs Lawyer Paul Hanly on What a Settlement Might Look Like
Paul Hanly, Jr., 66, is one of three plaintiffs lawyers who has been appointed to lead the more than 430 (and counting) lawsuits in federal court that have been brought against the nation's biggest opioid manufacturers and distributors.
More from Opioid Watch